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Abstract 
Though child mortality in Sub-Saharan Africa has declined since 2000, they are still higher than other regions of 
the world. This has provided impetus for increasing effectiveness of health expenditure through improved quality 
of governance in the health sector. Dynamic panel estimation method was used to estimate panel data for 41 SSA 
countries for the period 2000 to 2009. The results show that public health expenditure relative to private health 
expenditure led to fall in under-five mortality rates in SSA. When corruption was controlled for effectiveness of 
public health expenditure on reducing under-five mortality was evident. Additionally, regional variations in 
effectiveness of health expenditure on under-five mortality was also realized. SSA countries are likely to benefit 
from reduced corruption which has an impact on effectiveness of health expenditure on child health outcomes.  
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1. Background 
Promotion of good health for children has featured prominently in international agenda. For instance, one of the 
Millennium Development Goals (MDGs) is to reduce child mortality rates by two-thirds in the developing world 
by 2015 (United Nations, 2000). However, this target is unlikely to be met (United Nations, 2011). Healthy 
children attain more education, high labour productivity as adults and therefore enhance economic growth 
(Amiri and Gerdtham, 2013; Belli, 2005; Stenberg, et al. 2014; DSAED, 2010). This potential benefit provides 
an impetus for provision of adequate health services to the children.  
Since 1990, under-five mortality rates have declined across the world. Over the period 2000-2011, 
average under-five mortality rates across the world declined by 30% compared to 16% during the period 1990-
2000 (Table 1).  However, compared to other regions of the world Sub-Saharan Africa (SSA) had the highest 
under-five mortality rates. Additionally, large differences were observed in under-five mortality rates within 
SSA. West and Central Africa had the highest under-five mortality rate (132) compared to Eastern and Southern 
Africa (84) in 2011. Thus, despite the decrease in some countries SSA is far from achieving the MDG to lower 
under-five mortality rates by two-thirds in 2015. Only Botswana, Cape Verde, Eritrea, Ethiopia, Liberia, 
Madagascar, Malawi, Mauritius, Niger, Rwanda, Senegal, Tanzania and Zambia might achieve the MDG target. 
Table 2 provides a summary of the factors that may have contributed to the decline in under-five 
mortality rates in SSA and corresponding quantitative indicators. The decrease in under-five mortality rates 
during the period 2000-2011 coincided with increases in public health spending in some SSA countries. A 
possible reason for the increase in health spending maybe the Abuja Declaration of 2001 that sought to increase 
public health spending in SSA. At the same time, there has been increased donor funding of health programmes 
from US$ 1.4 billion in 2002 to US$ 8.7 billion in 2010 (Wexler, et al., 2013). These interventions have reduced 
death from malaria (World Health Organization, 2011); Measles and Pertussis; infectious diseases such as 
Cholera; and from HIV/AIDS related illnesses (UNAIDS, 2012).Other factors which might have influenced the 
reduction in under-five mortality rates in the period 2000-2011 are as follows. Growth in the real income per 
capita which improved standard of living and access to resources (Houweling et al., 2005; Anyanwu and 
Erhijakpor, 2007; Yaqub, et al., 2012). Improved literacy levels for mothers improves their capacity and enables 
them to consume and access quality health care for their children (Anyanwu and Erhijakpor, 2007). Increased 
participation of women in labour force enhances their earning power, therefore influencing household quality of 
life through good nutrition (Farag, et al., 2013). Improved quality of governance through reduced corruption 
levels is likely to result in efficient use of resources in the health sector (Gupta et al., 2000; Yaqub, et al., 2012).  
Despite reduction in under-five  mortality rates in  SSA from 154 per 1000 live  births  in 2000 to 109 
per 1000 live  births in 2011, under five  mortality is relatively  high in SSA compared  to other regions where 
the rates are below 100 (UN Inter-Agency, 2012). Unless the under-five mortality rates in SSA are reduced, 
there are likely to affect negatively the human capital reserve and future economic gains in SSA. However, 
research evidence on the factors that reduce under-five mortality rates is inconclusive (Novignon, et al., 2012).  
Public health expenditure is a key policy instrument expected to reduce under-five mortality rates 
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(Anyanwu and Erhijakpor, 2007). However, previous studies relating health expenditure to reduction of child 
mortality have been inconclusive. Anyanwu and Erhijakpor (2007), Novignon, et al. (2012) and Issa and 
Ouattara (2005) found that in SSA increasing health expenditure would significantly reduce child mortality rates. 
Studies of other regions and  those of  developing  countries  have also provided similar  evidence (Farahani, et 
al., 2010; Bhalotra, 2006; Houweling, et al., 2005; Muldoon, et al., 2011; Farag, et al., 2013). However, some 
studies did not find significant link between health expenditure and child mortality (Gupta, et al., 1999; Yaqub, 
et al., 2012; Gani, 2008). Thus the issue of whether public health spending has an impact on under-five mortality 
is still not settled.   
It has been argued that poor governance is a possible explanation for ineffectiveness of public 
spending to reduce under-five mortality rates (Rajkumar and Swaroop, 2008). In particular, high corruption 
levels are likely to cause inefficiency in health service delivery. This involves embezzlement of funds, health 
staff absenteeism, and irregular procurement due to bribery and kickbacks, drugs and equipment pilferage and in 
kind payments (Lewis, 2006a; Savedoff, 2006). The  average  corruption perception index  for  Sub-Saharan 
Africa was 3.02  (out  of a scale  of 1 to 10) for  the  period  2000-2009 indicating  that corruption is a  problem 
in SSA (Teorell, et al, 2011). A very small number of studies examine the effect of good governance in 
improving child health. These studies suggested that good governance can reduce child mortality directly and by 
enhancing the effectiveness of public health expenditure (Yaqub, et al., 2012; Rajkumar and Swaroop, 2008; 
Gupta, et al., 2000; Farag, et al., 2013).  
Most studies of the impact of health expenditure on child mortality do not take into account dynamics. 
Some have used ordinary least squares OLS (e.g.  Houweling, et al., 2005; Rajkumar and   Swaroop, 2008; 
Yaqub, et al., 2012) while others use static panel data models (e.g. Novignon, et al., 2012; Farag, et al., 2013). 
Few studies have examined whether the impact of health expenditure on child mortality depends on the quality 
of governance, that is, the interaction between health expenditure and governance. It is also not known how the 
effect of health expenditure on child mortality varies within SSA regions. Such information is necessary for 
understanding problems arising from poor governance and how they affect effectiveness of health expenditure. 
Additionally, investigating differences in the effectiveness of health expenditure in SSA region may provide a 
platform for region specific solutions to reduce child mortality.  
The main aim of this study is to examine the relationship between health expenditure and under-five 
mortality and the role of governance environment within which health spending occurs in Sub-Saharan Africa. 
Specifically, this study estimates the impact of health expenditure and under-five mortality in SSA;  tests 
whether effect of health expenditure on under-five mortality in SSA depends on level of corruption; examines 
whether there are regional differences in the relationship between health care spending, level of corruption and 
under-five mortality in SSA.  This study provides new evidence on relationship between health expenditure and 
under-five mortality in the post Abuja declaration era.  With exception of Novignon, et al. (2012) who used static 
models there is limited literature on relative effects of public and private health expenditure on child mortality in 
SSA. Other existing studies such as  Anyanwu and Erhijakpor  (2007) focus only on  the  effects  of  total and  
public  health expenditure  on under-five  mortality. The current study departs from existing studies in SSA by 
using panel data to examine the effects of corruption and how corruption levels influence effectiveness of health 
expenditure on under-five mortality.  
The relevance of the study arises from the fact that reduction of child mortality in SSA is a priority 
agenda in policy makers’ perspective. The MDG goal on reducing child mortality to a third of 1990 levels is still 
being implemented till 2015 and is not likely to be met by many SSA countries. Furthermore, reduction in under-
five mortality is necessary for human capital stock, future investments and future workforce availability. Policy 
makers  are  therefore  likely to benefit  from the  knowledge  of  how  health expenditure has  impacted  on child  
mortality since  the Abuja declaration on public  health expenditure. This provides an impetus for assessment of 
success of the policy in improving child health in SSA over the last decade. Understanding how quality of 
governance especially levels of corruption has affected  child mortality directly and  its  impact on effectiveness  
of public health expenditure provides  a  platform for  controlling  corruption in the  health sector.  
Furthermore, existing studies of the impact of health expenditure on under-five mortality rates have not 
examined the potential regional heterogeneity across SSA sub-regions. Given varied policies and health systems 
the effectiveness of health expenditure on under-five mortality in SSA is likely to differ across sub-regions. This 
study provides evidence on these differences. Increasing interest in regional integration makes comprehension of 
regional variations in effectiveness of health expenditure and quality of governance on reduction of child 
mortality in SSA relevant. This contributes to policy prescriptions that are focused on solving regional specific 
concerns on health expenditure, levels of corruption and child mortality. Unlike previous studies for SSA this 
study used a larger sample. The application of the linear dynamic panel model (GMM-IV) is a departure from 
previous studies that use OLS, fixed effects and random effect estimators. The dynamic GMM-IV technique 
introduces dynamics, control for endogeneity and heterogeneity as well as ensuring stationarity. Hence more 
robust estimates than in the other static panel models are achieved. This study is a benchmark for future research 
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in SSA on health expenditure, corruption and child mortality. This is through expansion of the subject matter 
within region analysis (Eastern Africa, Western Africa, Central Africa and Southern Africa). Research can focus 
on differences in income grouping and how they allocate resource to the health sector. This is likely to inform 
policies relevant to reduction of under-five mortality in the long-run. Research can also focus on measures of 
corruption in the health sector and how it affects child mortality and effectiveness of public health expenditure 
when such data become available.   
The remainder of this paper is organized as follows; section 2, presents the literature review. Section 3, 
outlines the methodology used in the paper. Section 4, presents the descriptive statistics and econometric results. 
Section 5, presents a summary, conclusion and policy implications. 
 
2. Literature Review 
Several studies have examined the relationship between different categories of health expenditure and child 
mortality using different types of data and estimation methods. The results differ across studies. Some studies 
found no effect of health expenditure on child mortality (e.g. Gupta, et al., 1999 (total health expenditure); Gupta, 
et al., 2001 (private health expenditure)). Others found limited effect (e.g. Filmer and Pritchett, 1999) and yet 
others have found strong effect of health expenditure on child mortality ( e.g. Houweling, et al., 2005; Bokhari, 
et al., 2007; Baldacci, et al., 2003; Anyanwu and Erhijakpor, 2007; Novignon, et al., 2012) .  
The first strand of literature are the cross-sectional studies relating health expenditure and child 
mortality. These studies include Houweling, et al. (2005), Bokhari, et al. (2007), Baldacci, et al. (2003),  Gupta, 
et al. (1999; 2001), Filmer and Pritchett (1999) and Gottret and Schieber (2006). Houweling, et al. (2005) 
examined the effects of public health expenditure on under-five mortality rates in a sample of 43 countries in 
Africa, Asia and Latin America with emphasis on differential impact among the rich and poor. OLS estimates 
indicated that a 10% increase in public health expenditure per capita would decrease under-five mortality rates 
by about 1.1% (rich) to 2.4% (poor). The weakness of this study emanates from not accounting for potential 
endogeneity of health expenditure in the under-five mortality equation which could occur because of reverse 
causality.    
Using a sample of 127 developed and developing countries, Bokhari, et al. (2007) studied the link 
between per capita public health expenditure and under-five mortality rates. Unlike Houweling, et al. (2005) the 
paper  controlled for endogeneity of health expenditure and real per capita GDP by using instrumental variable 
generalized method of moments-Heteroscedastic OLS estimator (GMM-HOLS) and Heteroscedastic Two-stage 
Least Squares (GMM-H2SLS). The estimated elasticities imply that a 1% increase in per capita  public health 
expenditure reduced under-five mortality by 0.34% and 0.52% for developed and developing countries 
respectively. Though the study used GMM models the type of data used does not account for dynamics.  
Baldacci, et al. (2003) estimated the relationship between 3-year (1996-1998) averages in public health 
expenditure and both infant and under-five mortality rates for 94 developing and transition economies. To 
account for potential endogeneity of health expenditure and heteroscedasticity in the cross-sectional data, 
Weighted Two stage Least Squares (WTSLS) was used. The cross-section results indicated that an increase in 
public health expenditure by 1% resulted in decline of under-five mortality rate by about 0.22%. For the infant 
mortality rate, a rise in public health expenditure by 1% reduced it by 0.13% to 0.22% across three estimation 
methods (OLS, 2SLS and WTSLS). Baldacci, et al. (2003) also treated health status (infant and under-five 
mortality) as a latent variable and used covariance structure model to determine its relationship with government 
health expenditure. They found insignificant relationship between health expenditure and both infant and under-
five mortality. Even when the income group of a country was taken into consideration, the coefficient of public 
health expenditure was still insignificant in the health status equation. The authors argued that such a model is 
appropriate as health status is multidimensional and unobservable and cannot be measured by health indicators. 
Similarly, Gupta, et al. (1999) applied OLS and 2SLS to investigate the effects of total health spending 
and public spending on primary health care (public expenditure on clinics and practitioners or on preventive 
health) on under-five mortality rates in 50 developing countries and transition economies. They found that an 
increase in primary health care expenditure by 1% reduced under-five mortality rates by 0.97% and 0.95% 
respectively. The estimation results also indicated that total health expenditure as percent of GDP did not 
significantly affect under-five mortality rates. The authors identified two weakness of the study. First, non-
uniform definition of primary health expenditure across countries. Second, potential correlation between the 
control variables measles immunization rates and adult illiteracy. Furthermore, due to inconsistencies in data the  
sample size  used  was far below the  initial 50 observations (30 in OLS and 29 in 2SLS) this  leaves  very few 
degree of  freedom which may affect robustness  of  the estimates  realised  in the  study.  
In another study, Gupta, et al. (2001) examined the separate effects of public and private health 
expenditure on under-five mortality rates among the poor and non-poor households in 70 countries. The OLS  
estimates showed  that an increase  in public  health expenditure  per  capita by 1%  reduced under-five mortality 
rates  by between 0.3%  to 0.32%  in the  poor  households. But private health expenditure had insignificant 
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effect. For the non-poor households, the results indicated that an increase of 1% in public and private health 
expenditure per capita led to a decline in under-five mortality rates by 0.23% and the range of 0.28% to 0.43% 
respectively. Just as the Houweling, et al. (2005) study, the paper does not account for endogeneity of health 
expenditure and under-five mortality. Filmer and Pritchett (1999) like Gupta, et al. (1999) applied OLS and 
2SLS to examine the impact of public health spending on child and infant mortality using cross-section of 98 
countries. The OLS estimates showed that an increase in public health expenditure by 1% led to a fall in under-
five mortality by 0.14% at 10% significance level indicating a weak link. However, once the potential 
endogeneity of health expenditure was addressed through 2SLS, the effect of health spending on child mortality 
was insignificant. The authors do not include the effects of private health expenditure on under-five mortality.  
Gottret and Schieber (2006) used several methods (OLS, Heteroscedastic OLS, 2SLS and generalized method of 
moment Heteroscedastic 2SLS) to investigate the relationship between government health expenditure and 
under-five mortality rates in 2000 for 113 countries. The OLS estimates indicated that increase in government 
health expenditure by 1% reduces under-five mortality by 0.17%. This result is lower than those which 
controlled for endogeneity (2SLS and GMM-H2SLS) which ranges from 0.34% to 0.4%. One of the cross-
sectional studies focusing on effect of corruption on provision of health services is Gupta, et al. (2000). The 
study analysed data averaged for the period 1985-1997 for each of 128 developed and developing countries 
using OLS and 2SLS. The OLS baseline estimates indicated that unit increase in corruption levels raised child 
mortality and infant mortality by 0.37 and 0.35 per 1000 live births respectively. When level of corruption was 
conditioned on income, the impact of corruption increased under-five and infant mortality by 0.13 and 0.14 per 
1000 live births respectively. When endogeneity was accounted for through 2SLS unit increase in corruption 
levels raised child mortality by 0.10 per 1000 live births respectively. The authors concluded that lowering 
corruption was essential for better health outcomes. 
The overall results from the cross-sectional studies are inconclusive. Some studies (Houweling, et al., 
2005; Baldacci, et al., 2003; Bokhari, et al., 2007; Gupta, et al., 1999; Gottret and Schieber, 2006; Gupta, et al., 
2001) have found a reducing and significant effect on under-five mortality. On the other hand, some studies such 
as Filmer and Pritchett (1999) even after controlling for endogeneity found insignificant relationship between 
public health expenditure and child mortality. In addition Gupta, et al. (2001) found insignificant link between 
private health expenditure and under-five mortality while Gupta, et al. (1999) found insignificant relationship 
between total health expenditure and under-five mortality. Gupta, et al. (2000) found a significant increase in 
child mortality and infant mortality when level of corruption is high. The estimated magnitudes of the effects of 
health expenditure on child mortality vary widely across the studies reviewed. In cross-sectional studies temporal 
dynamics are not accounted for because of their one period nature. 
The second strand of literature are studies that used time series data to determine the relationship 
between health expenditure and under-five mortality. Time series studies provide a trend and temporal 
perspective. Such studies can be used to project future patterns of behaviour of both health expenditures and 
child mortality. Anand and Ravallion (1993) examined the impact of public health expenditure per capita and 
infant mortality rate in Sri Lanka. They used data for 1952-1981. OLS estimates showed that increasing public 
health expenditure per capita by 1% reduced infant mortality by about 0.33%. However, this study neither 
controlled for potential endogeneity of public health expenditure in the infant mortality equation nor examined 
the time series properties of the data used. Thus the estimated relationship maybe spurious. Yaqub, et al. (2012) 
estimated the impact of public health expenditure and governance on under-five mortality rates in Nigeria using 
OLS and 2SLS. The study covers 1980 to 2008. They estimated the direct effect of public health expenditure on 
under-five mortality and the interaction effect between public health expenditure and corruption levels. Without 
the interactive variable the OLS and 2SLS estimates indicate that increasing public health expenditure by 1% 
increases under-five mortality rates by 0.03% and 0.05% respectively.  In the model with the interactive variable, 
the level of corruption significantly reduced under-five mortality and the interaction between public health 
expenditure and level of corruption is positive and significant. In the 2SLS, increasing public health expenditure 
by 1% at the mean of corruption level (0.78) in Nigeria raises under-five mortality rates by 0.01%. The study 
used small sample (30 observations) such that with several explanatory variables few degrees of freedom are 
available for statistical inferences. The paper does not also examine the time series properties of the data. Thus 
the estimation results maybe spurious. In general time series studies do not control for unobserved heterogeneity. 
Second, the studies focus on a single country or region. This may impede generalisation of the study results to 
other countries. 
The third strand of studies used panel data. The use of panel data to analyse the effect of health 
expenditure on child mortality presents some advantages over both cross-sectional and time series data. With 
panel data the number of observations increases and it is also possible to control for unobserved country specific 
effects. 
One category of panel data studies related total and public health expenditure effects on child mortality 
(Anyanwu and Erhijakpor, 2007; Baldacci, et al., 2003; Gani, 2008). Anyanwu and Erhijakpor (2007) focused on 
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health expenditure and under-five mortality rates in Africa. The study used a panel of 47 countries for the period 
1999-2004. The authors applied three estimation methods, robust Ordinary Least Squares (ROLS), and robust 
Two-stage Least Squares (R2SLS) to account for endogeneity and fixed-effect estimator to account for 
unobserved heterogeneity. The paper found that an increase of 10% in per capita total health expenditure would 
decrease under-five mortality rates by the range of 1.7% to 6.3%. Additionally, an increase in public per capita 
health expenditure by 10% would reduce under-five mortality rates by the range of 1.8 % to 2.5% across the 
three estimation methods.Applying a fixed effects model to data from seven Pacific Islands, Gani (2008) 
examined the effects of per capita public health expenditure on infant and under-five mortality for selected 
periods between 1990 and 2002. The fixed effects estimation was corrected for auto-regression of order one. The 
study found an insignificant relationship between per capita public health expenditure and under-five mortality. 
On the other hand, increasing per capita public health expenditure reduced infant mortality by 0.66%.  This study 
did not control for potential endogeneity of health expenditure. The size of the sample used was small (n=28) 
such that with 12 explanatory variables few degree of freedoms for hypothesis testing are left. Baldacci, et al. 
(2003) estimated the impact of public health expenditure on under-five mortality using two estimators; feasible 
generalised least squares (FGLS) and Arellano-Bond GMM-IV. The results for FGLS and Arellano-Bond 
indicated that an increase in public health expenditure by 1% reduced under-five mortality rates by 0.28% and 
0.14% respectively. But FGLS estimates showed that increasing public health expenditure by 1% increased 
infant mortality by 0.06%. The strength of this study is that it accounts for dynamics and potential endogeneity 
of health expenditure in the under-five mortality equations estimated by GMM. 
Another category of panel data studies consider the impact of public and private health expenditure on 
health outcomes (example, Freire and Kajiura, 2011; Novignon, et al., 2012). Freire and Kajiura (2011) 
examined the link between components of health expenditure and under-five mortality in Asia-Pacific countries. 
A Fixed effects model was estimated using panel data for the period 1990-2009. The authors found that a 1% 
rise in public health expenditure reduced under-five mortality rates by 0.06%. A 1% increase in private health 
expenditure reduced under-five mortality rates by 0.10%. However, the study does not account for potential 
endogeneity of public and private health expenditure in the estimated under-five mortality equation. Similarly, 
Novignon, et al. (2012) studied the effects  of  public and  private  health care expenditure on  infant mortality 
rates in a  panel of  44  Sub-Saharan Africa countries  for the  period  1995-2010 using fixed effect model. The 
results indicated that a 1% increase in total health expenditure reduced infant mortality by about 3 per 1000 live 
births. The results further show that increasing public and private health expenditure by 1% reduced mortality 
rates by 4.2 and 2.5 per 1000 live births respectively. A drawback of these results is that potential endogeneity of 
the health expenditure variables in both infant and under-five mortality equations was not taken into account.  
A third group of panel data studies examined the effect of governance measures on health outcomes 
(Rajkumar and Swaroop, 2008; Farag, et al., 2013; Hu and Mendoza, 2013). This emerging literature examined 
the role of governance environment on the effectiveness of health expenditure. Rajkumar and Swaroop (2008) 
investigated the relationship between public health expenditure and under-five mortality rates and how 
governance (corruption and quality of bureaucracy) affects the relationship. The study used a three year panel 
data (1990, 1997, and 2003) covering 91 developed and developing countries. Pooled OLS estimates indicated 
that a 1% increase in public health expenditure reduced under-five mortality by 0.18%. In the equation 
containing the interaction of public health expenditure and level of corruption, the public health expenditure 
estimate is insignificant while the interaction variable is negative and significant. However, the estimates may be 
biased as potential endogeneity of health expenditure in the child mortality equation was not controlled for. In 
Farag, et al. (2013) a link between health expenditure, infant and child mortality, and the role of governance in 
low and middle income countries is investigated. The paper applied fixed effect method of estimation to a panel 
of 133 countries for the years 1995, 2000, 2005 and 2006. The estimates showed that a 1% increase in total 
health expenditure reduced under-five mortality by the range of 0.15% to 0.38%. On the other hand, it lowered 
infant mortality by the range of 0.13% to 0.33%. Increasing government health expenditure reduced under-five 
mortality by a percentage ranging from 0.1 to 0.19 while private health expenditure reduced it from the range of 
0.07% to 0.08%. Additionally, a rise in government health expenditure by 1% led to a decline in infant mortality 
ranging from 0.08% to 0.17%, while increasing private health expenditure by 1% reduced infant mortality by the 
range of 0.05% to 0.07% respectively. The estimation results indicated that improving the level of government 
effectiveness1 reduced child mortality. The full effect of government health expenditure with respect to improved 
government effectiveness (evaluated at the mean) led to a reduction of under-five mortality ranging from 0.07% 
to 0.12%. However, the fixed effect estimator does not take into account potential endogeneity of health 
expenditure in both infant and under-five mortality equations.  Hu and Mendoza (2013) applied both fixed 
effects and 2SLS methods to investigate the link between public health expenditure and child mortality for 136 
                                                 
1 Is a variable that measures  the  ability of  the  government  to implement socially sound policy, that is, the  level and quality 
of  public  service provision and smooth function of  the bureaucracy (Kauffmann and Kraay, 2006; Farag, et al., 2013). 
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countries over the period 1960 to 2005. In the fixed effect model, a 1% increase in public health expenditure as a 
share of GDP reduced under-five mortality by 0.11%, while the interaction of public health expenditure and 
control of corruption was insignificant. Fixed effects estimates showed corruption coefficient was insignificant. 
The 2SLS was used to handle potential endogeneity of public health expenditure. The estimated effect however, 
was not significant. 
The literature on the relationship between health expenditure and child mortality has not yet come to a 
consensus. The problem arises because of uncertainty in the estimated effects of public health expenditure. The 
uncertainty can be attributed to use of different data types, inconsistent data, accounting or not accounting for 
endogeneity of health expenditure and unobserved heterogeneity in the methods of estimation. This study 
contributes to the debate by using a rich panel data set for SSA and linear dynamic panel model. It estimates the 
impact of various measures of health expenditure (total, public and private health expenditure) and governance 
on under-five mortality rates. The study also examines regional variations in how health expenditure and its 
interaction with governance affects under-five mortality in SSA.  
 
3. Methodology 
3.1 Conceptual Model for Health Expenditure, Corruption and Child Health  
Conceptually health spending is a function of the health system which enables the purchase of health goods and 
services. Increased allocation of health resources (especially, financial resources) by the government and private 
sector is likely to influence the quality of health service delivery. The conceptual model is summarized in Figure 
1. 
The improved health service delivery results in incremental effect on the quality of life and health 
capital to the beneficiaries (Grossman, 1972). This in turn leads to low mortality rates in children. Suppose the 
government invests the increased financial resources in child immunization (for instance, Measles); HIV/AIDS 
health programmes such as behavioural change education, antiretroviral therapy (ART), provision of condoms 
and post-exposure  prophylaxis; or family planning  services  to reduce fertility rates.  
Figure 1: Conceptual Model for Health Expenditure, Corruption and Under-Five Mortality 
 
Source: Author (motivated from theoretical models of; Rajkumar and Swaroop (2008), Filmer and Pritchett 
(1999) and Yaqub, et al., 2012). 
Curbing corruption increases transparency and accountability, thereby increasing effectiveness of 
health resources allocated to health. Lewis (2006a)  identified  issues  such as  absenteeism of  health staff, 
bribery for services, leakage  such as stealing  of  medical supplies as constituting most of  the  corruption in the  
health sector. Suppose we consider, the  continuous  presence  of staff in the  health care  facilities, availability 
of  drugs  in the  clinics would improve  service  delivery. This improved health service delivery would improve 
health of the beneficiaries which would lead to low child and adult mortality. Reduced embezzlement and 
diversion of health funds to other non-priority areas is likely to improve effectiveness of health spending. This is 
because the resources are employed where they are most needed. This would result in adequate health services 
which would eventually lead to low mortality rates. 
Regional differences may also influence effectiveness of health expenditure in reduction of adult 
mortality. This is  because  they have varied  health  policies  and  priorities  which are  likely to influence  child 
and adult  health in different  ways. The regions in the conceptual model are Eastern Africa, Western Africa, 
Southern Africa and Central Africa which are classified using United Nation country classification system 
(United Nations Statistics Division, 2013).  
 
3.2 Theoretical Model 
The health production function for estimating the relationship between health expenditure, corruption and child 
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health is adapted from Rajkumar and Swaroop (2008), Filmer and Pritchett (1999) and Yaqub, et al. (2012). The 
relationship can be expressed as follows. 
  				,	, ………………………………………….…………………(3.1) 
Where  is under-five mortality rates.   is real Gross Domestic Product per capita (real income per 
capita);   is health spending (total, public and private health care spending).  is the level of corruption. 
 is assumed to be technological changes, which are assumed to be constant. From Equation (3.1) the model 
assumes that; increase in real per capita GDP leads to a reduction in under-five mortality rates. The mechanisms 
through which real income per capita affects child health are: allocation of more financial resources to child 
health services. Health expenditure influences child health through the following channels: availability of child 
health focused interventions such as immunization, nutrition boosters and supplements and, child growth 
monitoring.  Health expenditure also facilitates availability of adequate health workers, drugs and medical 
supplies and infrastructure (clinics and hospitals) for provision of the child health related health services. 
Improving quality of governance by reducing corruption leads to a decline in under-five mortality rates. Low 
corruption environment is likely to promote transparency and accountability in provision of health services. 
Hence, reducing leakages which might affect effectiveness of health service delivery to children.  
Model (3.1) is transformed in a Cobb-Douglas health production model. The production function 
relates health status with health spending and real gross domestic product (GDP) per capita. It is augmented with 
corruption variable and this relationship is expressed as equation (3.2). 
………………………….…………….…..(3.2) 
Taking the logarithms of equation 3.2 transforms it into a linear equation (3.3). 
…………………….……...(3.3) 
The parameters are defined as follows:  is the coefficient of real GDP per capita; which measures the elasticity 
of under-five mortality rates with respect to change in income.  is the elasticity of under-five mortality rates 
with respect to change in health expenditure and  is the elasticity of under-five mortality rates with respect to 
change in level of corruption. In equation 3.3 additional assumption is taken into consideration. The study 
assumes that some part of health spending (total, public and private) is lost or wasted due to corruption. This 
wastage has consequences on the effectiveness of health spending in a given country or region. 
Following Yaqub, et al. (2012) and Pritchett (1996) and assuming  .   is a part of resources allocated to health 
that is spent on productive purposes,  the  coefficient of health spending on, say programme  takes the form; 
…………………………………………………………………………..……. (3.4) 
Where   represents the productivity of public or private capital that is created from spending on health 
programme		. Assuming that .  measures the effectiveness of health spending which is a function of level of 
corruption	 !, then,   
………………………………………………………………………...... (3.5) 
Substituting equations (3.4) and (3.5) into (3.3) results into the following equation; 
………(3.6) 
Breaking down equation (3.6) leads to equation (3.7) 
….. (3.7)  
Where "  is the coefficient of the log of health expenditure and  is the coefficient of the interaction of 
corruption index and log of respective health expenditure. 
 
3.3 Empirical Models 
In order to investigate the impact of health expenditure on under-five mortality rates, three models are specified. 
The first model contains health expenditure and a set of control variables. This is the baseline model to study the 
relationship between health expenditure and under-five mortality rates. It is written as follows. 
 ……………………………………………...(3.8) 
The model in equation (3.8) was extended to include the corruption perception index to yield the following 
model. 
..................................................(3.9) 
In order to investigate how level of corruption influences the effect of health expenditure on child mortality 
equation (3.9) was extended with interaction between health expenditure and corruption, to yield. 
………………………
………………………………………………….........(3.10) 
The equations (3.8), (3.9) and (3.10) relates natural log of under-five mortality rates (#$  !) to the natural log 
of health expenditure (#$	 !, the natural log of corruption index (#$ !, the interaction between the 
natural log of health expenditure and corruption index ( ! ∗ #$	 !, and a vector of control variables. 
&'(   are control variables which include: the natural log of real GDP per capita, total fertility rates, HIV 
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prevalence rates, the natural log of ethnic fragmentation, measles immunization rates, the natural log of female 
literacy and female labour  force participation rate.  
The coefficients  are the coefficient estimates of health spending and are expected to be 
negative.  are coefficients of level of corruption and are expected to be negative.  is the coefficient 
of the interaction term and can take positive or negative sign.   is the coefficient for the vector of control 
variables.    and  are the composite error terms which consists of country specific effects and time-
specific effects. The composite error terms are assumed to be normally distributed and homoscedastic. 
In order to investigate regional differences in effects of health expenditure and corruption on under-
five mortality rates equations (3.8), (3.9) and (3.10) are extended to include dummy variables of SSA sub regions 
and their interactions with health expenditure and level of corruption. 
The baseline model to test for regional differences in the effects of total health expenditure on under-five 
mortality rates is written as follows. 
..........(3.11) 
When level of corruption and interactions with the regional dummy variables are included the model is as 
follows. 
 (3.12) 
Further extension introduces interaction between regional health expenditure and corruption to obtain the 
following model. 
 + 
) ! …………………………………………..(3.13) 
Equations (3.11), (3.12) and (3.13) relates natural log of health expenditure, regional dummy variables Eastern 
Africa (EA), Central Africa (CA), Western Africa (WA), interaction of regional dummy variables and natural 
log of health expenditure, interactions of regional dummy variables and natural log of level of corruption and the 
interactions of regional dummy variables, levels of corruption and natural log of health expenditure. The 
Southern Africa (SA) dummy variable and its interactions are dropped from the model to avoid the dummy 
variable trap. ,  and  are composite error terms for the respective equations. 
 
3.4 Estimation 
Health expenditure could be potentially endogenous in under-mortality equations in the presence of 
measurement errors, omitted variables and reverse causality. For instance, economic adjustments, changes in 
population characteristics and political regime changes or upheavals are likely to be omitted variables correlated 
with health expenditure. Other concerns are problems of unobserved heterogeneity and lagged dependent 
variable in dynamic models. Estimation under these statistical challenges can produce inconsistent and biased 
estimates. Therefore an econometric strategy based on dynamic panel estimators was used to allow for 
instrumental variables.  Specifically, the Generalized Method of Moments instrumental variable linear dynamic 
panel model was used. Linear Dynamic Panel Data (LDPD) is a hybrid model emanating from works of Arellano 
and Bond (1991), Arellano and Bover (1995) and Blundell and Bond (1998). It combines the properties of the 
Arellano-Bond GMM and Systems GMM estimators. The specified models were estimated using instruments in 
both differences and levels. Diagnostic tests for validity of instruments (Sargan test), overall significance of 
explanatory variables (Wald test) and autocorrelation (Arellano-Bond tests) were carried out. Table 3 shows the 
variable and the source of data. 
 
4. Empirical Results 
4.1 Descriptive Statistics 
In Table 4 the mean under-five five mortality rate was 114.9 per 1000 live births across 41 SSA countries. The 
average public health spending was about US$ 759 million (2000, constant).  Average private health care 
spending was higher at US$ 1,130 million. This shows that total health care spending at US$ 1,890 million, 
would  hide the  observation that private  health expenditure is almost one and  half times  public  health 
expenditure. Out-of-pocket health spending is the largest component of private health care spending. In 28 
countries, it is about 70% of private health care spending.  This suggests that many inhabitants of SSA are 
vulnerable to poverty when faced by high health expenditures. Mean Corruption Perception Index was 3.02. 
Because a corruption index of one denotes high corruption and corruption index of ten denotes low corruption, a 
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corruption index of three indicates that corruption was rampant in most of the SSA countries over the period 
covered.  
Average real GDP per capita was US$ 3,259.4 (PPP, 2005 International) with a large standard 
deviation. The average HIV prevalence rate was about 6.2% but in one country it was 26.3%.  On average, SSA 
had 4.9 children per woman (a proxy for household size), and female labour force participation averaged 62.7% 
of the economically active population. Average female literacy measured as primary school gross enrolment 
ratio in Sub-Saharan was at 92.1.  However, Niger had very low female literacy rates at 26.5.  The average ethnic 
fragmentation index (a proxy for social cohesion) was 0.63 (maximum possible index is 100). This indicates that 
ethnic fragmentation is high in Sub-Saharan Africa.  
 
4.2 Econometric Results: Health Spending, Corruption and Under-Five Mortality Rates in Sub-Saharan 
Africa 
This section presents the econometric results for the effects of health care spending and level of corruption on 
under-five mortality rates in Sub-Saharan Africa. The results are presented in sections 4.2.1 and 4.2.2 
respectively. The estimation results of equations (3.8), (3.9) and (3.10) are presented in this section. In the 
remainder of this study, the interpretation of the results is based on linear dynamic panel GMM model estimates.  
4.2.1 Total Health Expenditure, Corruption and Under-Five Mortality Rates 
Table 5 shows the estimated effects of total health expenditure and corruption on under-five mortality rates. 
Model 1, is baseline model measuring the effects of total health expenditure on under-five mortality rates. Model 
2, has an additional variable measuring the effect of corruption on under-five mortality rates. Model 3, 
determines the effectiveness of total health expenditure on under-five mortality rates with respect to change in 
corruption level. This is achieved by adding an interaction between level of corruption and health expenditure. 
The  diagnostic  tests  used  for model 1 to 3 of  the  linear dynamic  panel are  the  Wald  criterion, Sargan test 
and  Arellano-Bond  autocorrelation test. Wald test in all the three models is significant at 1% rejecting the null 
hypothesis that there is no joint significance of the coefficients. The p-value for the Arellano-Bond test are large 
indicating that the null of no serial correlation in the first difference errors cannot be rejected. Sargan test for 
over-identification restriction validity show that the null hypothesis cannot be rejected. Thus instruments used in 
three GMM models are valid. 
The estimated coefficient of total health spending in model 1 of Table 5, is negative and significant at 
1% level. An increase in total health spending by 1% would reduce under-five mortality by about 0.14% 
annually in SSA. This result is consistent with that of Anyanwu and Erhijakpor (2007) and Farag, et al. (2013). 
But it differs from that of Gupta, et al. (1999) who found a positive but insignificant effect of total health 
expenditure on under-five mortality rates. However, these studies used different models from the one used in the 
study.  The estimated coefficients of the control variables also show significant and correct signs in model 1. The 
exception is female literacy coefficient which is positive and significant. This may imply that as more female are 
getting educated they are likely to work away from home. Consequently, they delegate caring of their children to 
third party reducing the motherly attention (such as, providing emergency health care when children are ill 
unexpectedly) which is crucial for children under-five years. 
Model 2 repeats the estimation but includes natural log of corruption index. The coefficient of total 
health spending is negative and significant but of smaller absolute magnitude. Increasing total health spending 
by 1% decreases under-five mortality rate by about 0.1%. The coefficient of natural log of corruption perception 
index is negative and significant. A 1% increase in the corruption index (increase implies lower levels of 
corruption) decreases under-five mortality by about 0.11%. The results are consistent with those of Yaqub, et al. 
(2012). In contrast, Hu and Mendoza (2013) and Rajkumar and Swaroop (2008) found positive and insignificant 
impact of corruption perception index on under-five mortality. Gupta, et al (2000) found a positive relationship 
between corruption (where 1; low corruption and 10; high corruption) and child mortality.  The control variables 
still have expected signs and significantly influence under-five mortality rates. However, the sign of female 
literacy is still positive. 
The estimation results under Model 3 include the interaction term between level of corruption and 
health expenditure. The estimated coefficient of total health expenditure, level of corruption and the interaction 
term are significant. The control variables exhibit the expected signs (except for female literacy) and are all 
significant (except for measles immunization rate) determinants of under-five mortality rates. Table 6 displays 
the derived estimates of effectiveness of total health expenditure on under-five mortality rates. The estimated 
coefficient of total health expenditure and that of the  interactive  variable were used to compute  the 
effectiveness of  total health expenditure  evaluated  at the  minimum, maximum and  mean values  of  the  
corruption perception  index.  Table 6 indicates that when level of corruption is perceived to be high   (CPI =1), 
increasing   total health spending by 1% reduce under-five mortality rate by about 0.42%. But when level of  
corruption is  perceived to be  low (CPI =6.4), 1%  increase in total health spending decreases under-five 
mortality rates by about 0.32%.  The lower effectiveness of total health expenditure on under-five mortality 
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when corruption is perceived to be low than when it is perceived to be high could imply seekers of health service 
may be willing to participate in corruption to receive health care service (Gupta, et al., 2000).  Subsequently, 
health sector personnel who control resources are likely to perpetuate corruption (Vian, 2008; Lewis, 2006b). If 
they are motivated to work better in a highly corrupt environment there is a likelihood of lower child mortality.  
4.2.2 Public and Private Health Expenditure, Corruption and Under-Five Mortality Rates 
Econometric results of the effect of public and private health spending and, corruption on under-five mortality 
rates are shown in Table 7. The results are displayed in three models. The baseline model (Model 4) includes 
public and private health expenditure and the set of control variables. Modell 5 extends model 4 by including 
corruption perception index to measure the effect of corruption on under-five mortality rates. Model 6 includes 
all variables in model 5 and adds interaction terms between corruption index and natural log (public health 
expenditure) and, between corruption index and natural log (private health expenditure). The aim is to determine 
the effectiveness of both public and private health expenditure on under-five mortality rates. 
The p-value (0.00) for Wald test indicate that the null hypothesis of no joint significance in the 
coefficient estimates can be rejected. The Arellano-Bond test for autocorrelation shows that the null hypothesis 
of no serial correlation cannot be rejected as the p-values are more than 0.10. The p-value of Sargan test shows 
the over-identification restrictions are valid. Thus, the instruments used are valid. 
The results for model 4 show that coefficient of public health expenditure is negative and significant 
while that of private health spending is positive and insignificant. Increasing public health expenditure by 1% 
decreases under-five mortality by about 0.24%. The insignificant private health expenditure coefficient may be 
due to crowding out effect because of the relatively strong effect of public health expenditure in reducing under-
five mortality. The public health expenditure results are consistent with those of Novignon, et al. (2012) and 
Freire and Kajiura (2011). However, the two studies found that private health expenditure had a negative 
significant effect on under-five mortality rate. It is vital to note that the two studies have applied different models 
and estimation methods to the one used in this study. Except for female literacy the coefficients of control 
variables in model 4 are significant and have expected signs. 
When the corruption perception index is included (Model 5) the coefficient of public health 
expenditure is still negative and has significant effect on under-five mortality while private health expenditure is 
insignificant.  In this case an increase in public health spending by 1% leads to a reduction in under-five 
mortality by about 0.13%.  These results imply that when we control for corruption the effect of public health 
expenditure on under-five mortality is smaller. The coefficient on level of corruption is negative and significant 
at 1% level. Increasing the CPI by 1% (lower level of corruption) reduced under-five mortality by about 0.51%. 
The results for effect of corruption on under-five mortality rates are consistent to those of Yaqub, et al. (2012). 
In contrast, Hu and Mendoza (2013) and Rajkumar and Swaroop (2008) found a positive and insignificant 
effects of corruption on under-five mortality rates.  Gupta, et al. (2000) found that higher corruption levels had a 
positive effect on under-five mortality. The estimated coefficients of intervening variables have expected signs 
(except for female literacy) and are significant. 
The results above indicate that public health expenditure is more relevant in reducing child mortality in 
SSA than private health expenditure. This maybe because most childhood health intervention are public funded. 
Most health services (such as immunizations; ART therapy for HIV expectant mothers and children infected; 
vitamin supplements as well as child growth monitoring) for children under-five years are provided free in 
public health entities in most of SSA countries.  
The interaction variables between public and private health expenditure components and the corruption 
index (Model 6) are significant.  The estimate of interaction between corruption index and public health 
expenditure is negative while that of corruption perception index and private health expenditure is positive. 
Similarly, Rajkumar and Swaroop (2008) found a negative coefficient for interaction between public health 
expenditure and corruption perception index. In contrast, both Hu and Mendoza (2013) and Yaqub, et al. (2012) 
found positive effect of interactions of public health expenditure and corruption index on under-five mortality 
but the former had insignificant estimates.  The control variables estimates in the model exhibit expected signs 
(except for measles immunization and female literacy) and are significant.  
The net effects of public and private health expenditure taking into account their interaction with the 
corruption perception index are derived and presented in Table 8. The net effect is evaluated at the mean, 
minimum and maximum levels of corruption. The estimates  of  public and  private  health expenditure and  the  
interactive  variables  are  obtained  from Table  7.The estimates in Table 8 show that in high corruption scenario 
(CPI = 1)  1% increase in public health expenditure increases under-five mortality rate by 0.12% while private 
health spending  reduced under-five mortality rate by about 0.26%.  Increasing public spending on health care by 
1% in a country with average level of corruption (CPI = 3) increases under-five mortality by about 0.02%.  But 
raising private health spending by 1% reduces under-five mortality by about 0.14%. In low corruption 
environment (CPI = 6.4), an increase in public health spending by 1% leads to a fall in under-five mortality by 
about 0.16%. But increasing private health spending by 1% increased under-five mortality by about 0.08%.The 
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results indicate that when corruption is perceived to be low (high CPI) the effectiveness of public health 
spending on under-five mortality increases. In contrast, when corruption is perceived as high (low CPI) private 
health expenditure effectiveness is high.  
 
4.3 Regional Differences in the Impact of Health Care Spending and Corruption on Under-Five Mortality 
Rates 
Equations (3.10), (3.11) and (3.12) estimations are presented in this section. Regional differences in the effect of 
health care spending (total, public and/or private) and level of corruption on under-five mortality rates results are 
presented in sections 4.3.1 and 4.3.2 based on GMM-IV linear dynamic panel estimates. The estimated results 
are shown in Tables 9, 10, 11 and 12. 
4.3.1 Regional Based Total Health Expenditure, Corruption and Under-Five Mortality Rates 
The regression results for the relationship between total health expenditure, corruption and under-five mortality 
are presented in Table 9. The econometric estimates are displayed in three models. To investigate whether the 
impact of total health expenditure and perceptions about corruption differs across regions within SSA, these 
variables were interacted with three dummy variables for Eastern Africa, Central Africa and Western Africa. 
Southern Africa dummy is omitted to avoid dummy variable trap. The estimation results of under-five mortality 
equation with interaction terms are reported in Table 9. 
The Wald test p-value (0.00) indicates that the null hypothesis of no joint significance is rejected and 
the three GMM models are well fitted. The p-value for Arellano-Bond test shows that the null hypothesis of no 
serial correlation in the first difference errors cannot be rejected. The Sargan test cannot reject the null 
hypothesis of over-identification restrictions being valid as the p-value is large. 
The parameter estimates of the variables of interest (health expenditure, corruption perception index 
and interaction terms) were used to derive the effectiveness of health expenditure on under-five mortality rate for 
the different SSA sub-regions. Table 18 shows estimates of the effectiveness of total health expenditure. The 
reference sub-region is Southern Africa. In the baseline model (model 7a) increasing total health expenditure by 
1% reduced under-five mortality in Southern Africa by 0.36%, followed by Eastern Africa (0.24%), Central 
Africa (0.11%) and Western Africa (0.08%). So, total health expenditure reduces under-five mortality most 
effectively in Southern Africa. When effect of corruption level is taken into account (Model 8a) the magnitudes 
of the effectiveness of total health expenditure across the four regions change. For instance, effectiveness of total 
health expenditure in Western Africa and Central Africa is greater than the other two regions. On the other hand, 
effectiveness of Southern Africa and Eastern Africa total health expenditure is reduced when we control for 
corruption levels. Raising total health expenditure by 1% reduces under-five mortality by 0.87% and 0.33% for 
Western and Central Africa respectively.  
Table 10 also shows that there are regional differences in effectiveness of reduced corruption levels on 
under-five mortality. In particular, lowering corruption levels in Southern Africa is more effective in reducing 
under-five mortality, than the other three regions. When corruption levels are dropped by 1% under-five 
mortality in Southern Africa is reduced by about 0.87%, 0.5% in Eastern Africa and 0.11% in Western Africa. In 
contrast in Central Africa, reduced level of corruption increases under-five mortality by 0.09%.  Model 9a was 
used to investigate how perceived corruption levels affects the effect of total health expenditure on under-five 
mortality. Western Africa exhibits higher effectiveness of total health expenditure than the other three regions. 
At average corruption perception index (CPI = 3), increasing total health expenditure by 1% in Western Africa 
reduced under-five mortality by about 0.74%  compared with 0.13% in Central Africa. But 1% increase in total 
health expenditure raise under-five mortality by 0.08% and 0.07% in Southern Africa and Eastern Africa 
respectively.   
4.3.2 Regional Based Public and Private Health Expenditure, Corruption and Under-Five Mortality Rates 
This section presents estimates of the effect of public and private components of health expenditures and 
perceived corruption levels on under-five mortality rates in SSA sub-regions. The results are presented in Table 
11. The estimated equations are similar to those estimated in section 4.3.1 except health expenditure is 
disaggregated into public and private components. Wald test reject the null of no joint significance of the 
coefficient estimates because the p-value is 0 in the three GMM models. Arellano-Bond test fails to reject the 
null of no serial correlation in the models specified as the p-value is large. Additionally, the Sargan test null 
hypothesis of over-identification restriction are valid cannot be rejected because the estimate of p-value is large. 
This show that the instruments used in the GMM models are valid. 
The econometric results in Table 11 are employed in Table 12 to derive effects of public and private 
health expenditure and corruption perception on under-five mortality rates in the SSA sub-regions.  Table 12 
corresponds to the models 10, 11 and 12 in Table 11. In Table 12, model 10a examines the baseline regional 
variations in public and private health spending effects on under-five mortality. The results indicate that Western 
Africa experiences high effectiveness in both public and private health spending in reducing under-five mortality 
compared to the other three regions. Increasing Western Africa public and private health spending by 1% reduce 
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under-five mortality by about 0.14% and 0.73% respectively. While increasing public health expenditure reduces 
under-five mortality by 0.11% in Central Africa and private health expenditure increases it by 0.21%. Southern 
Africa and Eastern Africa show deteriorating under-five mortality when public health spending is increased. 
However, when private health expenditure is increased by 1% under-five mortality decreases by 0.34% and 0.20% 
in both regions respectively.  The results reveal that on the extreme end, Eastern Africa and Southern Africa 
experience lower effectiveness of public health expenditure than that of their private health expenditure on 
under-five mortality. The strong effectiveness of private health expenditure substitutes the public health 
expenditure.  
When corruption index is factored in model 11a, effectiveness of public health spending in Southern 
Africa is higher relative to the other three regions. Increase in public health spending in Southern Africa by 1% 
reduces under-five mortality by about 0.15%. This is followed by Eastern Africa (0.09%) and Central Africa 
(0.04%) respectively. Private health spending effectiveness is greater in Eastern Africa relative to that of 
Southern, Western and Central Africa respectively. Increasing Eastern and Southern Africa private health 
spending by 1% reduces under-five mortality by about 0.23% and 0.19%.  By controlling for corruption in model 
11a, the Western Africa public and private health expenditure effects on under-five mortality deteriorates. 
Eastern Africa and Southern Africa public and private health expenditure turned out to be complementary rather 
than substitutes as in model 10a. Central Africa  maintains  the  relationship as  in model 10a where  its  public  
health expenditure  is  stronger  than  private  health expenditure  in reducing  under-five  mortality. 
Improvement in quality of governance by lowering corruption is vital for efforts to reduce under-five 
mortality in the SSA sub-regions. Reduced corruption in Eastern Africa is stronger relative to other regions. A 
reduction in the level of corruption in Eastern Africa by 1% reduces under-five mortality by about 0.41%. This is 
followed by Southern Africa and Western Africa while effect of corruption on under-five mortality is positive in 
Central Africa.   In model 12a, increase in public health expenditure at the average corruption perception index 
(CPI = 3) reduce under-five mortality in Southern and Eastern Africa more than in Western and Central Africa. 
Considering the average level of corruption in the Southern and Eastern Africa, a rise in public health 
expenditure by 1% reduces under-five mortality by 0.07% and 0.06% respectively. Southern Africa also has the 
most effective private health expenditure at the average corruption perception index than the other three regions. 
Increasing private health expenditure by 1% reduces under-five mortality in Southern Africa by 0.08%.  From 
the results discussed the effectiveness of public health spending and private health expenditure are still 
complementary in Southern Africa but substitutable in Eastern Africa. In Western Africa and Central Africa, if 
both public and private health expenditure are dependent on levels of corruption, the under-five mortality are 
high in both sectors.  
 
5. Conclusions  
This paper investigated the effects of health expenditure on child mortality and how governance (measured as 
corruption perception index) affects the relationship in SSA for the period 2000-2009. Although child mortality 
in SSA has been declining, under-five mortality are higher than the other regions of the world.  This study 
argued that policy measures to reduce child mortality in SSA are increasing health expenditure and reducing 
levels of corruption. Though there  have  been efforts to increase health expenditure through initiatives such as 
Abuja Declaration the pace of its  implementation is still slow in most of the countries ten years on (Tandon and 
Cashin, 2010). Meanwhile, the incidence  of  corruption in all sectors of  the economy is still a  big  challenge 
and  this  may  have  adverse effect on effectiveness of  resources allocated to the  health sector (Lewis, 2006a; 
2006b.The main purpose of this paper was to determine the effects of health expenditure and to assess the impact 
of governance on effectiveness of health expenditure on under-five mortality in the post Abuja Declaration 
period.  
The study used panel data for 41 countries and employed linear dynamic panel data model.  (LDPD). 
This  model is a  hybrid  of  the  dynamic  panel data  methods  developed  by Arellano and Bond  (1991), 
Arellano and Bouver (1995), and  Blundell and Bond  (1998).  The LDPD is the preferred model because it 
controls for endogeneity of health expenditure, allows for dynamics, unobserved heterogeneity and embodies 
stationarity restrictions. The study contributes to a small but potential expanding empirical literature on the role 
of governance environment plays in the relationship between health expenditure and child mortality. There is 
dearth of studies focusing on SSA and taking into account dynamics within panel data settings. 
The empirical results suggest that total health expenditure reduces under-five mortality in SSA. The 
results also show  that when public  health expenditure  is  stronger  in reducing  under-five mortality it crowds  
out  the relative effects of  private  health expenditure. Lowering corruption is essential in achieving low under-
five mortality rates.  
Further, the results suggest that effectiveness of health expenditure on under-five mortality differs 
across SSA region. Southern Africa and Eastern Africa total health expenditure is more effective in reduction of 
under-five mortality than the other three regions. But when effect of corruption is controlled for total health 
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expenditure has greater effectiveness in reducing under-five mortality rates in Western Africa and Central Africa.  
Southern Africa and Eastern Africa exhibit lower under-five mortality when corruption is reduced relative to 
other regions. Increasing total health expenditure when corruption levels are average, Western Africa region 
experienced high reduction in under-five mortality than the other three regions.  
The study also found that regional differences in the effect of public and private health expenditure on 
under-five mortality rate. Public and private health expenditure in Western Africa were more effective in 
reducing under-five mortality more than the other three regions. When corruption was controlled for, Southern 
Africa had the strongest public health expenditure while Eastern Africa had the strongest private health 
expenditure among the four regions. Reducing levels of corruption in both Southern Africa and Eastern Africa 
reduced under-five mortality rate more than Central and Western Africa. Increasing public and private health 
expenditure at average levels of corruption reduced under-five mortality in Southern Africa more than the other 
three regions.  
In conclusion adequate health expenditure is important for the reduction of under-five mortality rates 
in Sub-Saharan Africa. Additionally, reducing corruption leads to better child health and high effectiveness in 
health expenditure geared toward health care. There exist regional differences on the effects of health 
expenditure and corruption on child health across the four regions; Eastern Africa, Western Africa, Southern 
Africa and Central Africa. Effectiveness of health expenditure relative to corruption also differs across the 
regions. 
 The policy implications arising from the study are as follows. First, it reveals to policy makers the 
importance of allocating more resources to health care. Second, it provides a strong argument for commitments 
in the implementation of Abuja Declaration on public health expenditure targets by Sub-Saharan Africa 
governments. The issue of health expenditure effectiveness with regard to corruption is important to policy 
makers. Mitigating against corruption is likely to increase effectiveness of health expenditure, which would 
improve child health as result of efficient delivery of health service. Because private health expenditure is more 
effective in high corruption levels, anti-corruption measures may lead public health workers (those who moved 
their services to private sector) to transfer their services back to public health service. This is because health care 
seekers are likely to shift demand for health services towards public health sector because of increased 
effectiveness in service delivery.   
Understanding the regional differences in the effectiveness of health expenditure on child health is also 
relevant to policy makers. Coordinated efforts such as anti-corruption measures, provides a suitable environment 
for full implementation and assures success of joint health policies in SSA (AU’s Abuja Declaration on public 
health expenditure and the Ouagadougou Framework on primary health). The  success  of  the  joint  policies  
between governments  and  regional affiliations may promote  integration and support to countries with weak 
health  outcomes, such as  high child  mortality. 
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rates (Deaths per 1000 
live  births) 
MDG 
Target   
Decline in Under-Five 
Mortality Rates (%) 







Africa 163 141 100 54 39 13 29 
Sub-Saharan Africa 178 154 109 59 39 13 29 
Eastern and Southern Africa 162 135 84 54 48  17 38 
West and Central  Africa 197 175 132 66 33 11 25 
Middle East and North Africa 72 52 36 24 50 28 31 
Asia 85 65 44 28 49 24 32 
South Asia 119 89 62 40 48 25 30 
East Asia and Pacific 55 39 20 18 63 29 49 
Latin America and Caribbean 53 34 19 18 64 36 44 
Central and Eastern 
Europe/Commonwealth of Independent 
States 48 35 21 16 56 27 40 
World 87 73 51 29 41 16 30 
Source of Data: UN Inter-Agency (UNICEF, WHO, World Bank, UNPD and UN DESA) Child Mortality 
Estimation (2012).  
 
Table 2: Probable Factors Influencing the Decline in Under-Five Mortality Rates in SSA 
Percentage of Children Under-five 
Years Using Insecticide Treated Bed 
Nets (ITNs) 
3% (2000); 23% (2006); 24% (2008); 35% (2009); 50% (2011); 53% 
(2012). 
Results: Malaria specific mortality rates decreased by about 33% in 
SSA in the period 2000-2010 (World Health Organization, 2011b).  
Immunization Rates for Measles  
(%) of 12-23 months children) 
53% (2000); 69% (2008); 74% (2010); 73% (2012).  
Results: The  number of  deaths  averted from measles increased from 
197,900 in 2000 to 569,300 in 2010  (Simons, et al., 2012) 
Pregnant Women with HIV 
Receiving Anti-Retroviral Therapy 
to Prevent Mother to Child 
Transmission (MTCT)  
446,000(34%) in 2007; 576, 800 (45%) in 2008; 672,900 (54%) in 
2009; 674,000 (50%) in 2010.  
Results: Number of new pediatrics cases of HIV infections reduced 
from 430,000 in 2009 to 390,000 in 2010 (WHO, et al., 2011). 
Average Real Gross Domestic 
Product Growth (Annual %) 
6.4% (2004-2008); 5.4% (2010); 5.3% (2011); 5.1% (2012).  (World 
Bank, 2013) 
Female Literacy (% Gross enrolment 
rate for Primary Education ) 
74.8% (2000); 79.7% (2002); 85.6% (2004); 91.5 % (2006); 94.8% 
(2008); 95.8% (2010). (World Bank, 2013) 
Average Increase in Public Health 
Spending as % of Government 
Expenditure 
0.9% (2000); 8.5% (2002); 9.2% (2004); 9.6% (2006); 9.4% (2008); 
9.8% (2011); (World Bank, 2013) 
Women Empowerment (proxy for 
ability to earn income) - (Labor 
Force Participation Rates %) 
61.3 (2000);  62.7% (2006) ; 63.1 (2011) (World Bank, 2013) 
Governance (CPIA Quality of Public  
Administration Rating; low=1; 
high=6) 
Average of  2.9 (for  the  period 2005-2011) (World Bank, 2013) 
Governance; (CPIA Transparency, 
Accountability and Corruption in 
Public Sector rating; low=1; 
high=6). 
Average  of 2.8 (for  the  period 2005-2011) (World Bank, 2013) 
Poverty Reduction ( those  living 
under 1.25/day % of population 
55.7% (2002); 52.3% (2005); 49.2% (2008); 48.5% (2010). (World 
Bank, 2013) 
Sources of Data: Several World Malaria Reports (2008-2012); Global HIV/AIDS Response Reports (2006-2011); 
World Development Indicators (World Bank, 2013); WHO (Global Health Observatory, 2013).  
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Table 3: Data Sources and Definition of Variables 
Variable 
Name 
Description Data Source 
Under-five 
mortality rate  
Under-five mortality rate is the probability per 1,000 live births that a new-born 
baby will die before reaching age five, if subject to current age-specific mortality 
rates. This variable in specified in natural logarithm form.  
World  Development 
Indicators (World 
Bank, 2011)  
Public Health 
Expenditure  
Public health expenditure consists of recurrent and capital spending from 
government (central and local) budgets, external borrowings and grants 
(including donations from international agencies and nongovernmental 
organizations), and social (or compulsory) health insurance funds. Measured as 
the total public health expenditure. Measured in US$ millions. 







Private health expenditure includes direct household (out-of-pocket) spending, 
private insurance, charitable donations, and direct service payments by private 
corporations.  Measured as total private health expenditure. Measured in 
US$ millions  






Expenditure       
Total health expenditure is the sum of public and private health expenditures. It 
covers the provision of health services (preventive and curative), family 
planning activities, nutrition activities, and emergency aid designated for health 
but does not include provision of water and sanitation. Measured in 
US$ millions. 





Real GDP per 
Capita  
GDP per capita based on purchasing power parity (PPP). PPP GDP is gross 
domestic product converted to international US$ using purchasing power parity 
rates. Data are in constant 2005. 






Prevalence of HIV refers to the percentage of people aged 15-49 that are 
infected with HIV. 





Total fertility rate represents the number of children that would be born to a 
woman if she were to live to the end of her childbearing years and bear children 
in accordance with current age-specific fertility rates. (proxy for household size) 






Child immunization measures the percentage of children aged 12-23 months 
who received vaccinations before 12 months or at any time before the survey. A 
child is considered adequately immunized against measles after receiving one 
dose of vaccine. 





Reflects probability that two randomly selected people from a given country will 
not belong to the same ethno linguistic group. The higher the number, the more 
fractionalized is the society. The definition of ethnicity involves a combination 










The CPI focuses on corruption in the public sector and defines corruption as the 
abuse of public office for private gain. The surveys used in compiling the CPI 
tend to ask questions in line with the misuse of public power for private benefit, 
with a focus, for example, on bribe-taking by public officials in public 
procurement. The sources do not distinguish between administrative and 
political corruption. The CPI Score relates to perceptions of the degree of 
corruption as seen by business people, risk analysts and the general public and 







Female gross enrolment ratio is the ratio of total enrolment for primary 
education, regardless of age, to the population of the aged group that officially 
corresponds to the level of education shown. This is a basic measure for literacy 
as ability to read, write and speak. A proxy for female literacy. 







Female labour force as a percentage of the total shows the extent to which 
women are active in the labour force. Labour force comprises people of ages 15 
and older who meet the International Labour Organization's definition of the 
economically active population. 
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Table 4: Descriptive Statistics for Various Indicators in Sub-Saharan Africa over the Period 2001-2009 
Variable  Obs Mean Std. Dev Min Max 
Under-five mortality rate (UMR)  per 1000 live  births 410 114.9 43.6 13.5 217.8 
Public Health Expenditure (Million US$ Constant 2000) 410 759 2,160 4.98 15,700 
Private Health Expenditure  (Million Constant  2000 US$) 410 1,130    3,490 7.4 23,500 
Total Health Expenditure (Million US $ , Constant, 2005) 410 1890 5,620 14.1    39,200 
Real GDP per Capita ( Constant. 2005 , PPP  US$) 409 3259.4 4998.2 346.1    31738.2 
HIV Prevalence Rate (%) 370 6.2 7.1 0.1 26.3 
Measles immunization rates (%) 410 71.6 17.6 17 99 
Total Fertility Rate  (No of Children per Woman) 410 4.87 1.21 1.5 7.5 
Ethnic Fragmentation 410 0.63 0.23 0.01 0.93 
Transparency International-Corruption Perception Index 276 3.02 1.06 1 6.4 
Female Literacy 410 92.1 27.3 26.5 152.5 
Female Labor Force Participation Rate (%) 400 62.7 16.0 28.9 91 
 
Table 5: Effects of Total Health Expenditure and Corruption on Under-Five Mortality Rates (Dependent 
Variable is the ln (Under-Five Mortality Rates)) 
Independent  Variables Model 1 Model 2 Model 3 
FE RE LDPD FE RE LDPD FE RE LDPD 
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health expenditure ) 
























Number  of Observations 370 370 370 255 255 255 255 255 255 
F-Test, (p-value)  71.49  
(0.00) 
- - 90.55  
(0.00) 
- - 81.34  
(0.00) 
- - 
R-Squared 60.55  - 77.36 73.98 - 77.63 74.33 - 




 582.9 15583.2 
 (0.00) 











Sargan Test  , (p-value)   10.499 
(0.94) 
  21.129 
(0.33) 
   12.086 
(0.74) 
Arellano-Bond 
Autocorrelation test (AR)  z-
value (p=value) 
   
1.202 
(0.23) 
   
-0.266 
(0.79) 
   
0.581 
(0.56) 
Number of Instrumental 
Variables 
  28  29  27 
Notes: (1)  FE- Fixed Effects Model; RE- Random Effects Model; LDPD- Linear Dynamic Panel Data 
Model;  (2) t-values are for the FE Estimation, and z-values are for the RE and LDPD estimations are shown in 
the parentheses;  (3) Where p= are the probability values;    (4)  Instruments:   Model 1 (four years lagged ln 
(under-five mortality rate) (GMM), differences  of  total fertility rate, ln (real income  per capita), female  labour  
participation rate, measles  immunization rate and  ln (ethnic  fragmentation); levels, total fertility rates, ln (real 
income  per capita), female  labour force  participation rate, measles  immunization rate, ln (ethnic fragmentation) 
and  ln (total health expenditure):  Model 2 (  four period  lagged ln (under-five  mortality rate) (GMM), 
differences  of  log (corruption index), total fertility rate, ln (real income  per capita), female labour force  
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participation rate, measles  immunization rate, ln (ethnic  fragmentation)  and  the  ln (total health expenditure):  
levels, total fertility rate, ln (real income  per capita), female  labour  force  participation rate, measles  
immunization rate, ln (ethnic  fragmentation)  and  the  ln (total health expenditure):  Model 3  (four  period  
lagged ln (under-five  mortality rate) (GMM);  differences  of ln (real income  per capita) and female labour 
force  participation: levels,  levels,  ln (real income per capita), female  labour  force  participation rate, total 
fertility rate, ln (total health expenditure) and  the  measles  immunization rate.  
Table 6: Effectiveness of Total Health Expenditure on Under-Five Mortality Rates in Sub-Saharan Africa 
Based on Estimates of Linear Dynamic Panel Model 
Corruption Perception Index Mean Min Max 
3 1 6.4 
Coefficient of ln ( Total health expenditure) -0.433 -0.433 -0.433 
Coefficient of corruption Index*ln(total health expenditure) 0.051 0.017 0.109 
Net Effect -0.382 -0.416 -0.324 
Calculations based on estimates in Model 3 of Table 5. 
Table 7: Effects of Public and Private Health Expenditure and Corruption on Under-Five Mortality 
(Dependent Variable is the ln (Under-Five Mortality Rates)) 
Independent Variables  Model 4 Model 5 Model 6 
FE RE LDPD FE RE LDPD  FE RE LDPD  
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Corruption index*ln(private  health expenditure) 
























Number  of Observations 370 370 370 255 255 255 255 255 255 
F-Test, (p-value)  62.06 
 (0.00) 
- - 88.35 
 (0.00) 
-  79.78 
 (0.00) 
 - 
R-Squared 60.44 59.30 - 79.03 75.96  80.77  78.14 - 
Wald  Test  , (p-value) 


















Sargan Test  , (p-value) 
  9.696 
(0.96) 
  25.794 
(0.14)) 
  42.292 
(0.63) 
Arellano-Bond Autocorrelation test (AR)  z-value 
(p=value) 
  1.275 
(0.20) 
  -0.108 
(0.91) 
  1.452 
(0.15) 
Number of Instrumental Variables   29   30   59 
.Notes:  1) FE- Fixed Effects Model; RE- Random Effects Model; LDPD- Linear Dynamic Panel Data 
Model. 2) t-values are for the FE Estimation, and z-values are for the RE and LDPD estimations are shown in the 
parentheses.  3) Where p= are the probability values.  4) Instruments:  Model 4 (four  period lagged ln (under-
five  mortality rates) (GMM),  ln (private health expenditure), total fertility rates, ln (real GDP per capita), 
female labour  participation, measles  immunization rates and  the  ln (ethnic fragmentation): levels,  total 
fertility rates, ln (real income  per capita), female labour force participation, measles  immunization rate, ln 
(ethnic  fragmentation) and  the  ln (public health expenditure): Model 5 (four  period  lagged ln (under-five  
mortality rates) (GMM), ln (private  health expenditure), total fertility rate, ln (real GDP per capita), female 
labour force  participation, measles  immunization rates, ln (ethnic  fragmentation) and  the  ln (corruption index): 
levels, total fertility rate, ln (real GDP  per capita), female labour  force  participation, measles  immunization 
rates, ln (corruption index) and  the  ln (public  health expenditure:  Model 6 (four  period  lagged  ln (under-five  
mortality rate) (GMM) and  two period  lagged  interaction of  corruption index and  ln (public health 
expenditure)(ethnic fragmentation): levels,  ln (ethnic fragmentation).  
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Table 8: Effectiveness of Public and Private Health Expenditure on Under-Five Mortality Rates in Sub-
Saharan Africa Based on Estimates of Linear Dynamic Panel Model 
Corruption Perception Index (CPI) Mean (3) Min (1) Max (6.4) 
A.  Effectiveness of Public  Health Expenditure 
ln (public  health expenditure) 0.174 0.174 0.174 
Corruption index*ln (public  health expenditure) -0.156 -0.052     -0.332 
Net Effect 0.018 0.122 -0.158 
B. Effectiveness of Private  Health Expenditure 
ln (private  health expenditure) -0.328 -0.328 -0.328 
Corruption index*ln(private  health expenditure 0.192 0.064 0.410 
Net Effect -0.136 -0.264 0.082 
 Calculations based on estimates in Model 6 of Table 7. 
Table 9: Regional Differences of Total Health Expenditure and Corruption Influence on Under-Five 
Mortality (Dependent Variable is ln (Under-Five Mortality Rates)) 
Independent Variables Model 7 Model 8 Model 9 
FE RE LDPD FE RE LDPD FE RE LDPD 
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- - - 
Eastern African Dummy*Corruption Index *ln(Total health 
expenditure) 






Western African Dummy*Corruption Index*ln(Total health 
expenditure) 






Central  African Dummy*Corruption Index*ln(Total health 
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Number  of Observations 362 362 362 251 251 251 251 251 251 
F-Test, (p-value)  51.71 
(0.00) 
- - 55.16  
(0.00) 
- - 54.97 
(0.00) 
- - 
R-Squared 64.4 62.8 - 80.5 78.01 - 80.4 78.1 - 
Wald  Test  , (p-value) 




















Sargan Test  , (p-value) 
- - 23.22 
(0.33) 
- - 40.83 
(0.27) 
- - 43.62 
(0.18) 
Arellano-Bond Autocorrelation test (AR)  z-value (p=value)    
1.563 
(0.12) 
   
-0.347 
(0.73) 
   
-0.580 
(0.56) 
Number of Instrumental Variables   36   55   55 
Notes: (1) FE- Fixed Effects Model; RE- Random Effects Model; LDPD- Linear Dynamic Panel Data 
Model;   (2) t-values for FE Estimation, and z-values for RE and LDPD estimations are in parentheses;  (3) 
Where p= are the probability value;   (4) Instruments: 
Model 7 (three period lagged ln (real GDP per capita) (GMM), Western Africa dummy* ln (total 
health expenditure), total fertility rates, ln (under-five mortality rate), ln (total health expenditure), measles 
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immunization rates, and HIV prevalence rate: levels, measles immunization rate, HIV prevalence rate and female 
labour force participation).  Model 8 (two period lagged ln ( real GDP per capita) (GMM), HIV prevalence  rate, 
ln (under-five  mortality rate), Western Africa dummy* ln (total health expenditure)  and  Central Africa 
dummy* ln (total health expenditure): levels,  two period  lagged  differenced ln (total health expenditure) 
(GMM)  and  four period  lagged  difference ln (corruption index) (GMM),  ln (under-five  mortality rates), 
Western Africa  dummy* ln (total health expenditure), Central Africa dummy*ln (total health expenditure), 
Western Africa* ln  (corruption index) and  ln (female  literacy)).   Model 9 ( two period  lagged  ln (real GDP  
per capita) (GMM), HIV prevalence  rate, ln (under-five  mortality rate), Western Africa dummy*ln (total health 
expenditure), Central Africa*ln (total health expenditure) and  the  ln (female  literacy): levels, two period  
lagged  differenced  ln (total health expenditure) (GMM), four  period  lagged  ln (corruption index ) (GMM), ln 
(under-five  mortality rate), Western Africa  dummy* ln (total health expenditure), Central Africa dummy* ln 
(total health expenditure), ln (female  literacy), Western Africa dummy* ln (corruption index)).  
Table 10: Regional Differences of Total Health Expenditure and Corruption Effects on Under-Five 
Mortality Rates 
Dummy variables for the Region takes the value of 1; 0 otherwise.  Computation Based on LDPD 
Estimates 
Model 7a: Regional  Variations  of Total Health Care Spending  
Southern Africa Eastern Africa Western Africa Central Africa 
-0.356 -0.240 -0.075 -0.108 
Model 8a: Regional Variations  of Total Health Care Spending  and Corruption 
Southern Africa Eastern Africa Western Africa Central Africa 
-0.092  -0.350 -0.867 -0.327 
-0.870 -0.501 -0.114 0.088 
Model 9a: Regional Variations of Total Health Spending Efficacy ( Interaction -Regional Dummy* Total 
Health Expenditure* Corruption); Computed  using CPI  Values at the mean 
Southern Africa Eastern Africa Western Africa Central Africa 
0.075 0.067 -0.738 -0.126 
Note: (1) The computation are based on estimates in Table 17 and they correspond to models 7, 8 and 9; (2) 
Mean values of CPI are extracted from the descriptive statistics..  
Table 11: Regional Differences in Public and Private Health Expenditure, and Corruption Effects on 
Under-Five Mortality Rates (Dependent Variable is ln (Under-Five Mortality Rates)) 
Independent Variables Model 10 Model 11 Model 12 
FE RE LDPD FE RE LDPD FE RE LDPD 
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Eastern Africa  dummy* 




















Western Africa dummy* 




















Central African dummy* 0.104 0.112 -0.693 0.197 0.215 0.109 0.356 0.331 0.115 
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ln( public  health 
expenditure)  
(2.39) (2.69) (-4.75) (4.35) (4.38) (1.71) (2.07) (1.87) (0.52) 
Eastern Africa  dummy* 




















Western Africa dummy* 
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Eastern Africa  dummy* 
ln (corruption index) 






- - - 
Western Africa dummy*  
ln (corruption index) 






- - - 
Central African dummy*  
ln (corruption index ) 






- - - 
Eastern Africa  
dummy*corruption 
index* ln (public  health 
expenditure)  








index* ln (public  health 
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Central African dummy* 
corruption index* 
ln( public  health 
expenditure)  






Eastern Africa  
dummy*corruption 
index* ln (private health 
expenditure)  








index* ln (private health 
expenditure) 






Central African dummy* 
corruption index* 
ln( private  health 
expenditure)  
























Number  of Observations 362 362 362 251 251 251 251 251 251 
F-Test,  (p-value)  35.56 
(0.00) 
- - 49.49 
(0.00) 
- - 43.04 
(0.00) 
- - 
R-Squared 62.3 62.3 - 83.5 81.03 - 83.0 81.9 - 





















Sargan Test  , (p-value) - - 35.49 
(0.27) 
- - 47.836 
(0.80) 
- - 60.607 
(0.35) 
Arellano-Bond 
Autocorrelation test (AR)  
z-value (p=value) 
   
1.523 
(0.13) 
   
0.098 
(0.92) 
   
0.651 
(0.52) 
Number of Instrumental 
Variables 
  50 - - 80 - - 83 
Notes: 1) FE- Fixed Effects Model; RE- Random Effects Model; LDPD- Linear Dynamic Panel Data 
Model.    2)  t-values are for the FE Estimation, and z-values are for the RE and LDPD estimations are shown in 
the parentheses.  3) Where p= are the probability values.    4) Instruments: Model 10 (two period lagged ln 
(public health expenditure) (GMM), ln (real GDP  per capita) and  the  Eastern Africa dummy*ln (public  health 
expenditure): levels, one  period  lagged  ln (female  literacy) (GMM), ln (real income  per capita), Eastern 
Africa dummy*ln (public  health expenditure), ln (private  health expenditure), HIV prevalence rate, total 
fertility rates). Model 11 ( two period lagged ln (private  health expenditure)  (GMM), the  two period  lagged  ln 
(real GDP  per capita) (GMM), ln (public  health expenditure), the  ln (female  literacy), HIV prevalence  rates, 
total fertility rates, Central Africa dummy*ln (public  health expenditure), ln (corruption index), measles 
immunization rates: levels, the standard  instruments are  ln ( public  health expenditure), ln (female  literacy), 
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HIV prevalence  rates, total fertility rate, Central Africa dummy* ln (public  health expenditure), ln (corruption 
index) and measles  immunization rates). Model 12 ( two period  lagged  ln (private  health expenditure) (GMM), 
four  period lagged  ln (real GDP  per capita) (GMM) , four  period  lagged  ln (corruption index ) (GMM),  ln 
(public  health expenditure), ln (female  literacy), HIV prevalence rates and  total fertility rates: level,  ln (female  
literacy), HIV prevalence rates  and  total fertility rates).  
Table 12: Regional Variations of Public and Private Health Expenditure, and Corruption Influences on 
Under-Five Mortality Rates 
Dummy variables for the Region takes the value of 1; 0 otherwise.   
Computation Based on LDPD Estimates 
Model 10a: Regional  Variations  of  Public and Private Health Care Spending  
Southern Africa Eastern Africa Western Africa Central Africa 
0.585 0.711 -0.140 -0.108 
Southern Africa Eastern Africa Western Africa Central Africa 
-0.202 -0.344 -0.734 0.214 
Model 11a: Regional Variations  of Public  and Private  Health Care Spending  and Corruption 
Southern Africa Eastern Africa Western Africa Central Africa 
-0.151 -0.09 0.008 -0.042 
Southern Africa Eastern Africa Western Africa Central Africa 
-0.190 -0.234 0.163 0.211 
Southern Africa Eastern Africa Western Africa Central Africa 
-0.257 -0.410 -0.026 0.042 
Model 12a: Regional Variations of Public and  Private  Health Spending Efficacy ( Interaction  of 
Regional Dummy with Public and  Private Health Expenditure and Corruption); Computed  using CPI  
Values at the mean=3 
Southern Africa Eastern 
Africa 
Western Africa Central Africa 
-0.072 -0.064 0.018 0.017 
Southern Africa Eastern 
Africa 
Western Africa Central Africa 
-0.081 0.099 0.074 0.361 
Note: 1) Mean values of corruption index are extracted from the descriptive statistics; 3) the values of 
lnPHE, lnPrivHE and Regional Dummies are incorporated in the computation of   regional effectiveness with the 
corruption index at the mean. Note Southern Africa is reference region in the estimations. 
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